Cargando…

S100. EFFECTS OF CANNABIS USE ON BODY MASS, FASTING GLUCOSE AND LIPIDS DURING THE FIRST 12 MONTHS OF TREATMENT IN SCHIZOPHRENIA SPECTRUM DISORDERS

BACKGROUND: Acute cannabis use stimulates appetite, while general population studies suggest that chronic use is associated with reduced risk of obesity and other cardiometabolic risk factors. METHODS: In this study, we investigated changes in body mass index (BMI), fasting blood glucose and lipids,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheffler, Frederika, Kilian, Sanja, Chiliza, Bonga, Asmal, Laila, Phahladira, Lebogang, du Plessis, Stefan, Kidd, Martin, Murray, Robin, Forti, Marta Di, Seedat, Soraya, Emsley, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888530/ http://dx.doi.org/10.1093/schbul/sby018.887

Ejemplares similares

T86. RELEVANCE OF CANNABIS USE AS A PREDICTOR OF CLINICAL OUTCOME IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER PATIENTS OVER 24 MONTHS OF TREATMENT
por: Scheffler, Frederika, et al.
Publicado: (2020)

Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders
por: Phahladira, Lebogang, et al.
Publicado: (2020)

F106. STATE AND TRAIT RELATED NATURE OF INSIGHT IMPAIRMENT IN SCHIZOPHRENIA
por: Phahladira, Lebogang, et al.
Publicado: (2018)

Antipsychotic treatment effects and structural MRI brain changes in schizophrenia
por: Emsley, Robin, et al.
Publicado: (2023)

M122. DEPRESSION IN SCHIZOPHRENIA SPECTRUM DISORDERS: LONGITUDINAL COURSE AND THE RELATIONSHIP WITH OTHER CLINICAL PARAMETERS AND QUALITY OF LIFE
por: Phahladira, Lebogang, et al.
Publicado: (2020)

S201. HIPPOCAMPAL SUBFIELD VOLUMES AND CHANGE IN BODY MASS OVER 12 MONTHS OF TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDERS
por: Du Plessis, Stéfan, et al.
Publicado: (2020)

Instruments Measuring Blunted Affect in Schizophrenia: A Systematic Review
por: Kilian, Sanja, et al.
Publicado: (2015)

S108. ASSOCIATIONS BETWEEN GLOBAL BRAIN MEASURES AND STATE- AND TRAIT- RELATED SYMPTOM EXPRESSION OF SCHIZOPHRENIA
por: Asmal, Laila, et al.
Publicado: (2018)

Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia
por: Benelmokhtar, Jebril M., et al.
Publicado: (2021)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

Neurological Soft Signs, Spontaneous and Treatment Emergent Extrapyramidal Syndromes in Black Africans With First Episode Schizophrenia
por: Ojagbemi, Akin, et al.
Publicado: (2018)

Childhood trauma exposure and reward processing in healthy adults: A functional neuroimaging study
por: Hendrikse, Chanellé Juanita, et al.
Publicado: (2022)

Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia
por: Kilian, S., et al.
Publicado: (2017)

Associations of premorbid adjustment with type and timing of childhood trauma in first-episode schizophrenia spectrum disorders
por: Smit, Anna M., et al.
Publicado: (2021)

The nature of relapse in schizophrenia
por: Emsley, Robin, et al.
Publicado: (2013)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment
por: du Plessis, Stefan, et al.
Publicado: (2023)

Cognitive insight is associated with perceived body weight in overweight and obese adults
por: Suliman, Sharain, et al.
Publicado: (2021)

M102. MEASURING PHYSIOLOGICAL RESPONSES ASSOCIATED WITH SOCIAL STRESS IN A VIRTUAL ENVIRONMENT AND ITS RELATIONSHIP WITH CHILDHOOD TRAUMA IN EARLY SCHIZOPHRENIA - A PILOT STUDY
por: Du Plessis, Stéfan, et al.
Publicado: (2020)

T2. ADVERSE CHILDHOOD EXPERIENCES IN PEOPLE WITH SCHIZOPHRENIA
por: Klaunig, Mallory, et al.
Publicado: (2020)

Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review
por: Emsley, Robin, et al.
Publicado: (2018)

The burden of care, quality of life and depression in relatives of patients with serious mental illness treated at Lentegeur Hospital
por: Nhlabathi, Sihle, et al.
Publicado: (2018)

Sleep quality and neurocognitive functioning in metabolic syndrome
por: Suliman, Sharain, et al.
Publicado: (2018)

Race trouble: experiences of Black medical specialist trainees in South Africa
por: Thackwell, Nicola, et al.
Publicado: (2016)

Independent effects of posttraumatic stress disorder diagnosis and metabolic syndrome status on prefrontal cortical thickness and subcortical gray matter volumes
por: Luckhoff, Hilmar Klaus, et al.
Publicado: (2023)

Validation of the Montreal cognitive assessment against the RBANS in a healthy South African cohort
por: Beath, Natalie, et al.
Publicado: (2018)

The Potential Role of Regulatory Genes (DNMT3A, HDAC5, and HDAC9) in Antipsychotic Treatment Response in South African Schizophrenia Patients
por: O’Connell, Kevin Sean, et al.
Publicado: (2019)

A clinician-monitored ‘PTSD Coach’ intervention: findings from two pilot feasibility and acceptability studies in a resource-constrained setting
por: Bröcker, Erine, et al.
Publicado: (2022)

On discontinuing treatment in schizophrenia: a clinical conundrum
por: Emsley, Robin
Publicado: (2017)

Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions
por: Zitha, Eddy, et al.
Publicado: (2014)

S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
por: Quattrone, Diego, et al.
Publicado: (2020)

Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users
por: Johnson, Emma C, et al.
Publicado: (2022)

Doing their best: strategies used by South African clinicians in working with psychiatric inpatients across a language barrier
por: Kilian, Sanja, et al.
Publicado: (2015)

RNA-seq analysis of gene expression profiles in posttraumatic stress disorder, Parkinson’s disease and schizophrenia identifies roles for common and distinct biological pathways
por: Hemmings, Sian M. J., et al.
Publicado: (2022)

Anxiety Sensitivity in School Attending Youth: Exploratory and Confirmatory Factor Analysis of the 18-Item CASI in a Multicultural South African Sample
por: Martin, Lindi, et al.
Publicado: (2016)

Exploratory factor structure of the neurological evaluation scale in black africans with first episode schizophrenia
por: Ojagbemi, Akin, et al.
Publicado: (2016)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Cannabis Use and Cognition in Schizophrenia
por: Løberg, Else-Marie, et al.
Publicado: (2009)

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals
por: Argote, Mathilde, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_005a8cdpjs45185e1glnitkpf2